SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-014932
Filing Date
2023-08-14
Accepted
2023-08-14 17:27:57
Documents
18
Period of Report
2023-08-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrmy-20230814x8k.htm   iXBRL 8-K 86188
2 EX-2.1 hrmy-20230814xex2d1.htm EX-2.1 1031199
3 EX-99.1 hrmy-20230814xex99d1.htm EX-99.1 121734
4 EX-99.2 hrmy-20230814xex99d2.htm EX-99.2 47923
5 GRAPHIC hrmy-20230814x8k001.jpg GRAPHIC 1167
6 GRAPHIC hrmy-20230814xex99d1001.jpg GRAPHIC 747
7 GRAPHIC hrmy-20230814xex99d2001.jpg GRAPHIC 9992
  Complete submission text file 0001558370-23-014932.txt   1659692

Data Files

Seq Description Document Type Size
8 EX-101.SCH hrmy-20230814.xsd EX-101.SCH 3162
9 EX-101.LAB hrmy-20230814_lab.xml EX-101.LAB 15927
10 EX-101.PRE hrmy-20230814_pre.xml EX-101.PRE 10080
12 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20230814x8k_htm.xml XML 4878
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39450 | Film No.: 231172193
SIC: 2834 Pharmaceutical Preparations